EpiPen® 0.3mg Stock Shortage
Here is the latest important statement form Mylan about Epipen availability:
We would like to inform you about the potential limited availability of EpiPen® 0.3mg (Senior) stock in coming weeks. To minimize the impact of this supply situation on patients, we are monitoring the situation closely and have taken the following actions.
Centralised distribution of EpiPen® 0.3mg only.
- EpiPen® 0.3mg (Senior) stock is now kept at one warehouse at Alliance healthcare. This allows for better distribution of EpiPen® and reduces the risk of uneven distribution.
- Please be assured that deliveries will be made nationwide to pharmacies with a valid script for EpiPen® on a next day delivery upon receipt of an order before 5pm.
- EpiPen® 0.15mg (Junior) stock will be available to order from local Alliance Healthcare depots across the country as usual.
- Mylan is aiming to prioritise patients with anaphylaxis diagnosis to minimise the risk of anaphylaxis complications.
We are working diligently to minimise the effect on all patients and stabilise EpiPen® supply nationwide.
Should you still have difficulty in obtaining your EpiPen® you may contact Mylan customer services on +44 (0)1707 853 100. Mylan’s Medical information team may also be contacted for any medical information request on +44 (0)1707 853 000 select option 1.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard. Side effects should also be reported to Mylan pharmacovigilance team tel no: 0800 121182267 email:UKPharmacovigilance@mylan.com By reporting side affects you can help provide more information on the safety of this medicine.